Cytophage Technologies Inc.

Symbol: Private
Market Cap: Private
Sector: Biotechnology
  • Cytophage is a leading-edge Canadian biotechnology company that uses advanced molecular genetic techniques and synthetic biology to create highly effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security.
  • Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. Cytophage is a private company based in Winnipeg, and expects to be publicly listed on the TSX-V in late 2023.